Top Markets
Coin of the day
Diagnocure, Inc. Diagnocure, Inc.

Diagnocure, Inc.

DGCRF
Rang în acțiuni #41418
Diagnocure, Inc. is a Canadian life sciences company dedicated to developing... Diagnocure, Inc. is a Canadian life sciences company dedicated to developing and commercializing innovative products for cancer diagnosis. Its core business revolves around advanced molecular diagnostic tests designed for the identification and management of cancerous conditions. The company's portfolio includes the PCA3 test for prostate cancer diagnosis, as well as the Guanylyl Cyclase C (GCC) marker and the Previstage GCC colorectal cancer staging test, both vital for patients with colorectal cancer. They also offer PCP, a multi-marker diagnostic for prostate cancer. In addition to these tests, Diagnocure provides specialized services such as gene expression and copy number variation analysis, mutation detection, SNP genotyping, and comprehensive platform and laboratory environmental support. Established in 1994 as 9342-8530 Québec Inc. and previously known as DiagnoCure Inc., the company is headquartered in Quebec, Canada.
Preț acțiune
$0.0001
Ultima sincronizare: 2025-06-11
Capitalizare de piață
$21.52K
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
CA
Tranzacționează Diagnocure, Inc. (DGCRF)

Categorie

Istoric al prețului acțiunii pentru Diagnocure, Inc. (DGCRF)
Cel mai mare preț de închidere: $0.00 pe 2025-06-01

Cel mai mic preț de închidere: $0.77 pe 2012-06-01
Istoric al prețului acțiunii pentru Diagnocure, Inc. din 2012 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2025 0.00%
2024 9,900.00%
2022 -99.50%
2021 100.00%
2020 -50.00%
2019 -77.65%
2018 -14.62%
2017 -7.14%
2016 -98.56%
2015 -20.88%
2014 -39.86%
2013 -53.79%
2012 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$236.22 -4.39%
IE
$15.84 -13.29%
CN
$535.05 11.47%
CH
$172.19 -9.50%
CH
$2.37 -28.64%
CN